ATA168486A - Verfahren zur herstellung von neuen 2-halogen-nicergolinen - Google Patents

Verfahren zur herstellung von neuen 2-halogen-nicergolinen

Info

Publication number
ATA168486A
ATA168486A AT0168486A AT168486A ATA168486A AT A168486 A ATA168486 A AT A168486A AT 0168486 A AT0168486 A AT 0168486A AT 168486 A AT168486 A AT 168486A AT A168486 A ATA168486 A AT A168486A
Authority
AT
Austria
Prior art keywords
nicergolines
halogen
producing new
producing
new
Prior art date
Application number
AT0168486A
Other languages
English (en)
Other versions
AT390614B (de
Inventor
Gabor Chem Ing Dr Megyeri
Tibor Dr Keve
Bela Dr Stefko
Erik Chem Ing Bogsch
Janos Chem Ing Dr Galambos
Anna Kassai
Ferenc Dr Trischler
Eva Dr Palosi
Dora Dr Groo
Egon Dr Karpati
Zsolt Dr Szombathelyi
Laszlo Dr Szporny
Bela Kiss
Istvan Dr Laszlovszky
Erzsebet Chem Ing Lapis
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ATA168486A publication Critical patent/ATA168486A/de
Application granted granted Critical
Publication of AT390614B publication Critical patent/AT390614B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0168486A 1985-06-21 1986-06-20 Verfahren zur herstellung von neuen 2-halogen-nicergolinen AT390614B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852447A HU193782B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof

Publications (2)

Publication Number Publication Date
ATA168486A true ATA168486A (de) 1989-11-15
AT390614B AT390614B (de) 1990-06-11

Family

ID=10959403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0168486A AT390614B (de) 1985-06-21 1986-06-20 Verfahren zur herstellung von neuen 2-halogen-nicergolinen

Country Status (30)

Country Link
US (1) US4753949A (de)
JP (1) JPS62485A (de)
CN (1) CN1015365B (de)
AR (1) AR241533A1 (de)
AT (1) AT390614B (de)
AU (1) AU594686B2 (de)
BE (1) BE904957A (de)
CH (1) CH671018A5 (de)
CS (1) CS255875B1 (de)
DD (1) DD246111A5 (de)
DE (1) DE3620647A1 (de)
DK (1) DK292086A (de)
ES (1) ES8800953A1 (de)
FI (1) FI84605C (de)
FR (1) FR2583756B1 (de)
GB (1) GB2176788B (de)
HU (1) HU193782B (de)
IL (1) IL79179A0 (de)
IN (1) IN163116B (de)
IT (1) IT1204865B (de)
LU (1) LU86485A1 (de)
NL (1) NL8601612A (de)
NO (1) NO164099C (de)
PH (1) PH24732A (de)
PL (1) PL147390B1 (de)
PT (1) PT82808B (de)
SE (1) SE463716B (de)
SU (1) SU1445557A3 (de)
YU (1) YU107986A (de)
ZA (1) ZA864633B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193781B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228943A (en) * 1962-06-11 1966-01-11 Lumilysergol derivatives
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
GB1513322A (en) * 1976-01-09 1978-06-07 Farmaceutici Italia Heterocyclic ergoline derivatives
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
DE91652T1 (de) * 1982-04-13 1984-03-29 Farmitalia Carlo Erba S.p.A., 20159 Milano Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives

Also Published As

Publication number Publication date
ES8800953A1 (es) 1987-12-16
PT82808A (en) 1986-07-01
FR2583756A1 (fr) 1986-12-26
DE3620647A1 (de) 1987-01-02
IT1204865B (it) 1989-03-10
IT8620873A0 (it) 1986-06-20
GB2176788A (en) 1987-01-07
CN86104086A (zh) 1986-12-17
ES556359A0 (es) 1987-12-16
FI862635A (fi) 1986-12-22
LU86485A1 (de) 1986-12-02
GB2176788B (en) 1989-07-26
NO862493L (no) 1986-12-22
SE8602737D0 (sv) 1986-06-19
AT390614B (de) 1990-06-11
FI84605B (fi) 1991-09-13
PH24732A (en) 1990-10-01
AU594686B2 (en) 1990-03-15
AR241533A1 (es) 1992-08-31
CH671018A5 (de) 1989-07-31
YU107986A (en) 1988-04-30
HUT41024A (en) 1987-03-30
IN163116B (de) 1988-08-13
NO164099B (no) 1990-05-21
NL8601612A (nl) 1987-01-16
GB8615120D0 (en) 1986-07-23
PL147390B1 (en) 1989-05-31
PT82808B (pt) 1988-04-21
DK292086D0 (da) 1986-06-20
SE8602737L (sv) 1986-12-22
AU5891686A (en) 1986-12-24
CS255875B1 (en) 1988-03-15
JPH0529227B2 (de) 1993-04-28
DK292086A (da) 1986-12-22
FR2583756B1 (fr) 1990-01-12
CN1015365B (zh) 1992-02-05
IL79179A0 (en) 1986-09-30
NO164099C (no) 1990-08-29
SE463716B (sv) 1991-01-14
US4753949A (en) 1988-06-28
FI84605C (fi) 1991-12-27
JPS62485A (ja) 1987-01-06
BE904957A (fr) 1986-12-19
HU193782B (en) 1987-11-30
NO862493D0 (no) 1986-06-20
FI862635A0 (fi) 1986-06-19
DD246111A5 (de) 1987-05-27
SU1445557A3 (ru) 1988-12-15
ZA864633B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
ATA20485A (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
ATA28687A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
ATA257986A (de) Verfahren zur herstellung von neuen azetidinderivaten
AT386822B (de) Verfahren zur herstellung von neuen pyrrolderivaten
ATA193185A (de) Verfahren zur herstellung von neuen substituierten benzamiden
ATA143887A (de) Verfahren zur herstellung von neuen macrolid-verbindungen
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
ATA254886A (de) Verfahren zur herstellung von neuen mitomycin-c-analogen
ATA5985A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
AT386197B (de) Verfahren zur herstellung von neuen indolderivaten
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
AT386828B (de) Verfahren zur herstellung von neuen acylaminomitosanen
ATA273486A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
ATA258985A (de) Verfahren zur herstellung von neuen substituierten 7-oxomitosanen
ATA144987A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
AT384226B (de) Verfahren zur herstellung von neuen 4'-halogenanthracyclinglykosiden
ATA298586A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
AT384218B (de) Verfahren zur herstellung von neuen chinazolin-derivaten
ATA313686A (de) Verfahren zur herstellung von neuen carbapenemderivaten
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
AT387385B (de) Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen
AT386407B (de) Verfahren zur herstellung von neuen n-sulfamyl -3-halogenpropionamidinen
ATA52285A (de) Verfahren zur herstellung von neuen diazepinoindolen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee